— Published date: 1/15/2025
Value Proposition: Implantable electrode device that can treat a plurality of medical diseases by stimulating or inhibiting select regions of sympathetic nervous system.
Technology Description
Researchers at Washington University in St. Louis have developed “SIMP…
— Published date: 1/15/2025
Value Proposition: Implantable electrode device that can treat a plurality of medical diseases by stimulating or inhibiting select regions of sympathetic nervous system.
Technology Description
Researchers at Washington University in St. Louis have developed “SIMP…
— Technology Description
Researchers in Dr. Mohamed Zayed’s laboratory have developed a versatile, sealable valve system for airway management devices that can protect healthcare workers by reducing their risk of exposure to aerosolized SARS-CoV-2 and other pathogens during risky pulmonary pro…
— Technology Description
Researchers in Philip Mudd’s lab at Washington University have developed a blood biomarker test that detects impending respiratory failure before existing diagnostics. High levels of the biomarker IP-10 in the blood are correlated with the subsequent development of acu…
— Disease indication – SARS-CoV-2 infection (COVID-19)
Drug format – Chimeric monoclonal antibody
Drug class – Best-in-class
Research stage and Preliminary data – The inventors have developed and characterized this antibody, creating a chimeric version with a human IgG backbone. T…
| Name | # Summaries | Author |
|---|---|---|
| 15 | ||
| 13 | ||
| 15 | ||
| 26 | ||
| 14 | ||
| 14 |
Creating...
